These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24367151)

  • 21. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
    J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic analysis of the attenuation phenotype of poliovirus type 1.
    Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E
    J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor.
    Yanagiya A; Jia Q; Ohka S; Horie H; Nomoto A
    J Virol; 2005 Feb; 79(3):1523-32. PubMed ID: 15650178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dissemination pathways for poliovirus cells to animals models].
    Ohka S
    Uirusu; 2006 Jun; 56(1):51-8. PubMed ID: 17038812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reevaluate the effect of G-480 point mutation that determines the neurovirulence of type I vaccine polioviruses].
    Zhang Y; Yan DM; Wang DY; Zhao R; Zhang DY; Ye XF; Zhu SL; An HQ; Xu WB
    Bing Du Xue Bao; 2007 Jan; 23(1):1-8. PubMed ID: 17886713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
    Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
    Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.
    Levenbook I; Dragunsky E; Pervikovc Y
    Vaccine; 2000 Sep; 19(2-3):163-6. PubMed ID: 10930668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence.
    De Jesus N; Franco D; Paul A; Wimmer E; Cello J
    J Virol; 2005 Nov; 79(22):14235-43. PubMed ID: 16254358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
    Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
    Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice.
    Jia Q; Ohka S; Iwasaki K; Tohyama K; Nomoto A
    J Virol; 1999 Jul; 73(7):6041-7. PubMed ID: 10364356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
    La Monica N; Meriam C; Racaniello VR
    J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine.
    Kohara M; Abe S; Kuge S; Semler BL; Komatsu T; Arita M; Itoh H; Nomoto A
    Virology; 1986 May; 151(1):21-30. PubMed ID: 3008430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
    Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poliovirus spreads from muscle to the central nervous system by neural pathways.
    Ren R; Racaniello VR
    J Infect Dis; 1992 Oct; 166(4):747-52. PubMed ID: 1326581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Transgenic Mouse Model of Poliomyelitis.
    Koike S; Nagata N
    Methods Mol Biol; 2016; 1387():129-44. PubMed ID: 26983733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple pathways for establishment of poliovirus infection.
    Arita M; Ohka S; Sasaki Y; Nomoto A
    Virus Res; 1999 Aug; 62(2):97-105. PubMed ID: 10507320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
    Ren RB; Moss EG; Racaniello VR
    J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurovirulence.
    Wood D
    Dev Biol Stand; 1999; 101():127-9. PubMed ID: 10566785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.